Novel basic-substituted 5-halo-thienoisothiazol-3(2H)-one 1,1-dioxides, a process for the preparation thereof, and pharmaceutical preparations containing these compounds
US4929616A · kind A · utility
18Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 6, 1989 |
| Grant date | May 29, 1990 |
| Priority date | — |
| Expiry date | Feb 6, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a novel basic-substituted 5-halo-thienoisothiazol-3(2H)-one 1,1-dioxide of the formula ##STR1## in which R.sub.1 denotes hydrogen, (C.sub.1 -C.sub.4)-alkyl or halogen, PA1 R.sub.2 denotes halogen, and PA1 n denotes an integer from 2 to 6, the pharmaceutically acceptable acid-addition salt thereof, a process for their preparation, and their use in medicament for the treatment of anxiety states.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.